IDOSE TR (travoprost)
OPHTHALMIC ANTIGLAUCOMA AGENTS · OCULAR HYPERTENSION ·+1
AVEDRO/GLAUKOS
Drug class
Antiglaucoma Implant
The term "antiglaucoma implant" is an umbrella descriptive grouping rather than a single established pharmacological class, encompassing both surgical drainage devices and sustained-release pharmaceutical delivery systems. Read more about Antiglaucoma Implant
2 drugs in this class 2 manufacturers
Drugs in Antiglaucoma Implant
DURYSTA (bimatoprost)
OPHTHALMIC ANTIGLAUCOMA AGENTS · OCULAR HYPERTENSION ·+1
Allergan
Filter & compare in the drug finder →
Opens the drug finder with Antiglaucoma Implant preselected. Add indication or manufacturer filters there.
The term "antiglaucoma implant" is an umbrella descriptive grouping rather than a single established pharmacological class, encompassing both surgical drainage devices and sustained-release pharmaceutical delivery systems.
When used in reference to pharmacotherapy, these formulations—such as intracameral prostaglandin analog implants—are designed to deliver targeted medication directly into the ocular tissues over an extended duration.
Their primary therapeutic mechanism is to enhance aqueous humor outflow, thereby lowering intraocular pressure.
They are primarily indicated to manage open-angle glaucoma and ocular hypertension while circumventing the compliance challenges and ocular surface toxicity associated with daily topical eye drops.
-
fda.gov
The term "antiglaucoma implant" is an umbrella descriptive grouping rather than a single established pharmacological class, encompassing both surgical drainage devices and sustained-release pharmaceutical delivery systems
-
glaucoma.org
The term "antiglaucoma implant" is an umbrella descriptive grouping rather than a single established pharmacological class, encompassing both surgical drainage devices and sustained-release pharmaceutical delivery systems When used in reference to pharmacotherapy, these formulations—such as intracameral prostaglandin analog implants—are designed to deliver targeted medication directly into the ocular tissues over an extended duration They are primarily indicated to manage open-angle glaucoma and...
-
eyesurgeonspc.com
When used in reference to pharmacotherapy, these formulations—such as intracameral prostaglandin analog implants—are designed to deliver targeted medication directly into the ocular tissues over an extended duration
-
fda.gov
Their primary therapeutic mechanism is to enhance aqueous humor outflow, thereby lowering intraocular pressure They are primarily indicated to manage open-angle glaucoma and ocular hypertension while circumventing the compliance challenges and ocular surface toxicity associated with daily topical eye drops
-
rxlist.com
Their primary therapeutic mechanism is to enhance aqueous humor outflow, thereby lowering intraocular pressure
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.